Objective: Urinary incontinence (UI) impacts all aspects of life activities. This study aims to characterize change in mobility within the community utilizing the Life Space Assessment (LSA) questionnaire in women undergoing non-surgical UI treatment. Methods: This prospective cohort study, performed from July 2007 to March 2009, followed women seeking non-surgical UI treatment from an outpatient tertiary-care clinic and assessed their mobility and symptoms using LSA, Urogenital Distress Inventory (UDI-6), and Incontinence Impact Questionnaire (IIQ-7) at baseline and 2, 6, and 12 months post-treatment. Estimated Percent Improvement (EPI) and Patient Satisfaction Question (PSQ) were obtained post-treatment. The women were treated with multi-component behavioral and/or pharmacologic therapies, and we hypothesized that LSA would improve with treatment. Repeated measures analysis with Tukey's HSD and backwards selection linear regression model were performed. Results: 70 ambulatory, community-dwelling women, aged 65 years or older, seeking non-surgical care for UI were recruited. LSA score decreased from baseline to 2 months (mean ± SD; 63 ± 29 to 56 ± 28, p < 0.001) and was sustained at 6 and 12 months (54 ± 28, 54 ± 28). UDI scores improved from 36 ± 23 to 25 ± 24, p < 0.001, at 2 months, and improvement persisted at 6 and 12 months (22 ± 22, 21 ± 24). Improvements in UDI and patient perceived improvement in UI were not associated with LSA change. Age, race, and depression impacted LSA, which decreased 1-point for each additional year of age (p = 0.004), 6-points for each point higher on the Geriatric Depression Scale (GDS) (p = 0.002), and 6-point for African American race (p = 0.048). Conclusion: Decreased mobility represented by LSA was related to age, depression, and race, but not UI symptom improvement.
Introduction
Urinary incontinence (UI) prevalence ranges from 30% -50% and is associated with significant morbidity and impact on quality of life in older women [1] [2] . Non-surgical therapies provide successful short-term improvements and even cure in some women with UI [3] - [6] . These treatment regimens include medications and behavioral therapy, which is comprised of pelvic floor muscle exercises, fluid management, and bladder control strategies. In older women, UI has been shown to be associated with impaired mobility, functional limitations, and falls [7] - [12] . Conversely, the effect of treating incontinence on mobility is unknown.
Typically, mobility and functional status have been measured indirectly using surrogates, such as the 6-Minute Walk Test, Activities of Daily Living (ADLs), and Instrumental ADLs (IADLS), rather than directly measuring the patient's "real life" global mobility. The actual impact of conditions such as UI on global mobility may be underestimated using these surrogate measures [10] [13] [14] . The validated Life Space Assessment (LSA) for older adults was designed to fill this void by assessing global mobility from the patient perspective, with respect to activity in the home environment and community, over the previous 4 weeks [15] [16] . The LSA is based on a conceptual model of actual mobility as a series of concentric rings radiating from the room where a person sleeps, out through their home and town, to an unlimited space away. In fact, when studied in Alabama Medicare beneficiaries, IADLs and ADLs only accounted for 33% of the variance in LSA, highlighting the need to look at other factors impacting mobility [16] . The concept of Life-Space may be particularly important for women with incontinence due to fear of visible leakage or odor, and its potential impact on travel outside the home and within the community. Thus, we hypothesized that mobility may improve with successful treatment of incontinence.
The primary objective of this study was to assess changes in mobility, as measured by the LSA, prospectively over a 1-year period in community dwelling women 65 years of age and older who received individualized non-surgical treatment for UI.
Methods
After IRB approval, ambulatory women, aged 65 years or older, who were seeking non-surgical treatment for UI were recruited for participation in this study from July 2007 to March 2009. Women with dementia, current use of anti-muscarinic medication, neurological disease, poorly controlled medical disease (i.e. Hgb A1C > 9, decompensated congestive heart failure), elevated PVR (>150 cc), use of catheterization, unevaluated hematuria, current UTI, fecal impaction, recent bladder surgery, vaginal prolapse beyond the hymen, neuromodulation, bladder augmentation, and ongoing treatment for incontinence at other facilities were excluded.
Qualified participants provided written, informed consent and underwent a clinical evaluation including interview, physical examination, and validated questionnaires (Incontinence Impact Questionnaire (IIQ-7), Urinary Distress Inventory (UDI-6), Patient Satisfaction Question (PSQ), 5-item Geriatric Depression Scale (GDS)) [17] [18]. 6-minute walk and Charlson Co-morbidity Index, which is a weighted score based on comorbid disease, were also completed for each patient [19] [20] . Individualized non-surgical treatment was performed and included behavioral treatments with pelvic floor muscle exercises for improved strength and control, adaptive responses to sensation of urgency, bladder training to increase voiding intervals, stress strategies to avoid incontinence with activity, fluid management, and caffeine avoidance. Anti-muscarinic bladder medications were added as clinically indicated.
Patients were initially seen every 2 -3 weeks and then visits were spaced out to every 2 -3 months, after adequate symptom control had been achieved, and at one year. At 2, 6, and 12 months post initiation of therapy, patients were contacted by telephone for measurement of LSA. They also received the same questionnaires as at baseline, as well as the Estimated Percent Improvement measure, which they completed and returned by mail at those times. Two months (8 weeks) was chosen as the primary outcome time point as it is an assessment time point typically seen in conservative therapy (non-surgical) trials in incontinence [4] [5] [15] [16] . The 6 and 12-month outcomes were included to show the trajectory of LSA and the relationship between LSA and improvements or regression in symptoms.
A ten-point decline in LSA has been associated with stopping travel outside of one's town, so this decrease was selected as the clinically relevant cutoff for significant change in LSA [21] . Preliminary data for baseline LSA scores from 33 patients undergoing gynecologic surgery had a standard deviation (SD) of 27, which is a conservative overestimate of the SD on the change in LSA. Therefore, with alpha = 0.05, power = 0.80, SD = 27, and desired detectable difference of 10, the sample size needed was 59. Study enrollment was increased to 70 to allow for approximately 20% attrition.
Multivariable linear regression with backwards selection, including repeated measures analysis, was performed with known covariates in the model to explore for potential predictors of LSA. The backwards selection process starts with all baseline parameters and removes parameters until all are statistically significant while keeping the known covariates of LSA were age, income, transportation difficulty and race given by the participant. Repeated measures with Tukey's HSD assessed for improvements in UDI-6, IIQ-7, and EPI. Logistic regression was used to assess PSQ. Analysis was performed with JMP 8 (Cary, NC).
Results
At baseline, 70 patients were enrolled and participated in the study. At 2, 6, and 12 months 66, 67, and 64 patients, respectively, followed up which resulted in an 8.6% attrition rate by 12 months. Patient characteristics are shown in Table 1 . Mean age ± SD was 74.9 ± 6.8 years.
LSA score significantly decreased, reflecting lack of improvement, from baseline to 2 months (p ≤ 0.001) and was maintained at 6 months and 12 months (mean ± SD; baseline 63 ± 29, 2 months 56 ± 28, 6 months 54 ± 28, 12 months 54 ± 28) (Figure 1) . UDI scores improved from 36 ± 23 to 25 ± 24 at 2 months (p < 0.001), and improvement persisted at 12 months ( Table 2) . IIQ-7 scores did not significantly change at 2, 6, or 12 months (p = 0.345). Patient-reported Estimated Percent Improvement at 2 months was 45% and was maintained to 12 months (p = 0.509). Patient satisfaction reflected 23% of women completely satisfied, 58% somewhat satisfied and 19% not at all satisfied at 2 months, which did not change significantly up to 12 months (p = 0.554).
Multivariable backwards modeling, controlling for known covariates of LSA, did not find improvements in UDI score or patient perceived improvement in UI to be associated with LSA assessment (p > 0.05). However, each additional year of age was associated with a 1-point LSA decrease (p = 0.004), and each additional point on GDS was associated with a 6-point LSA decrease (p = 0.002). African America race was associated with a 6-point lower LSA (p = 0.048). Of note, BMI was eliminated as a potentially associated variable during the modeling.
Discussion
Non-surgical therapy for the treatment of symptomatic UI did not result in improvement in mobility, as measured by LSA scores over a 1-year period. Despite significant improvements in urinary symptoms after non-surgical treatment, there was no improvement in mobility. Community mobility actually declined overall for the participants in this study. Age, race, and depression were factors significantly associated with the decline in mobility. Among older women with UI undergoing non-surgical treatment, our findings can be used to counsel patients that treatment of UI alone may not result in improved community mobility. Perhaps the degree of improvement in urinary symptoms with this non-surgical treatment approach was not large enough to have an effect on improving community mobility in this cohort. A previous report noted the minimum clinically important difference for the long form UDI, which is scored 0 -300, to be an improvement of 35 points [22] . The short form UDI, which was utilized in this study is scored 0 -100. We found an improvement in UDI scores of 11 points at 2 months and 15 points at 12 months. If we conservatively assume that a one-half standard deviation change reflects a clinically important difference, that would be a 12 point reduction at both the 2 and 12 month time-points [23] . We nearly did have this degree of change in UDI-7 score at 2 months and did meet this threshold at 12 months. Regardless, we did not find a positive change in LSA scores paralleling improvement in UI symptoms. If improved urinary symptoms affect community mobility, it is possi-ble that either we did not impact incontinence sufficiently for a mobility improvement, to create a difference in mobility scores as measured by the LSA, or that the measurement of urinary symptoms with the UDI-7 was not a sensitive enough measure of improvement. We chose not to subdivide the LSA analysis into groups with large changes in UDI-7 versus groups with no change or worsening in UDI-7 as these divisions would decrease the population sizes and could potentially bias our findings. Additionally, we elected to report the a priori selected statistical analysis for this prospective study rather than changing to a retrospective analysis.
The actual decline in LSA scores that we noted among women with UI who sought conservative treatment were most likely influenced by other factors that also are associated with UI. Multiple studies have shown associations between depression or depressive symptoms and UI [8] [9] [11] [24] [25] . Quality of life and perception of one's health status also are correlated with depression and UI, and treating urgency UI has been shown to improve depressive symptoms [14] [26]- [31] . It is suggested from our results that the existence of depression over-rides improvement in UI symptoms. Depression is a modifiable condition, which when treated effectively could improve LSA. Interventions targeting depressive symptoms may augment the impact that treating UI has on an older patient's LSA. Older women may not be the only population where treating depression may have effects on UI as overweight women with depressive symptoms also report more UI and worse UDI scores [32] . Studies in Canadian and Australian women have also shown synergistic negative impact on QOL fordepression and incontinence [27] [28] . Future research with LSA in this population should also include a depression scale to account for confounding.
Strengths of this study include assessments with validated measures at 4 time points over a year while statistically adjusting for known covariates of LSA and multiple testing, and low attrition rate. Weaknesses include not having a control group, but we preferred to offer treatment per individualized usual care to all participants as they were recruited from a cohort of women seeking care. It is a disadvantage that the other, non-LSA mobility tests were only performed at baseline and not at post-treatment intervals as this may have given us complementary information regarding impact on mobility in a smaller life-space such as in the household. The tertiary care specialty clinic population may also limit generalizability to the primary care setting, and likewise, limiting the study to community-dwelling women may limit its application to women requiring residential care.
Conclusion
In conclusion, we did not find improvement in mobility within the community utilizing the validated LSA tool, with improvements in UI symptoms among women receiving non-surgical treatments per individualized usual care. However, larger cohort studies or clinical trials using the LSA when potentially greater improvements in UI are expected, such as surgical intervention, should be performed to better assess the relationship with UI and improvements in mobility related to urinary incontinence among older women.
